• 9330 Citations
1992 …2023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Hirano is Professor of Medicine at Northwestern University Feinberg School of Medicine. He attended college at Yale University, medical school at the University of Pennsylvania and completed his medical residency and GI fellowship at Beth Israel Hospital in Boston. He took a faculty position at the West Roxbury VA Medical Center and Harvard Medical School working in esophageal swallowing physiology before coming to Northwestern in 1998. He is currently serving as Vice-Chair for the American Gastroenterological Association’s Esophageal, Gastric and Duodenal (EGD) section, site principal investigator for the Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and the educational co-chair for International Gastrointestinal Eosinophil Researchers (TIGERS). Dr. Hirano has written over 150 scientific papers and textbook chapters that focus on esophageal and swallowing disorders. He has active grant support from the NIH and FDA. Dr. Hirano is on the editorial board for Clinical Gastroenterology and Hepatology. He received the Northwestern University School of Medicine Award for Outstanding Achievement in Gastroenterology in 2002 and Distinguished Service Award in 2013. Dr. Hirano has been recognized as one of the Chicago area’s “Top Doctors” by the Chicago Consumer’s Checkbook and by Best Doctors in America.

Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Swallowing disorders

Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Esophageal motility disorders, Gastroesophageal reflux disease, Swallowing disorders

Certifications and Licenses

Gastroenterology

Training Experience

1992Residency, Beth Israel Deaconess Medical Center, Boston
1995Fellowship, Beth Israel Deaconess Medical Center, Boston

Education/Academic qualification

MD, University of Pennsylvania

… → 1990

Research interests

  • Digestive System (including gallbladder and liver)

Fingerprint Dive into the research topics where Ikuo Hirano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Eosinophilic Esophagitis Medicine & Life Sciences
Esophageal Achalasia Medicine & Life Sciences
Deglutition Disorders Medicine & Life Sciences
Gastroesophageal Reflux Medicine & Life Sciences
Eosinophilia Medicine & Life Sciences
Eosinophils Medicine & Life Sciences
Esophagus Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2003 2023

Research Output 1992 2019

6 Citations (Scopus)

Conjunctivitis in dupilumab clinical trials

Akinlade, B., Guttman-Yassky, E., de Bruin-Weller, M., Simpson, E. L., Blauvelt, A., Cork, M. J., Prens, E., Asbell, P., Akpek, E., Corren, J., Bachert, C., Hirano, I., Weyne, J., Korotzer, A., Chen, Z., Hultsch, T., Zhu, X., Davis, J. D., Mannent, L., Hamilton, J. D. & 8 others, Teper, A., Staudinger, H., Rizova, E., Pirozzi, G., Graham, N. M. H., Shumel, B., Ardeleanu, M. & Wollenberg, A., Sep 1 2019, In : British Journal of Dermatology. 181, 3, p. 459-473 15 p.

Research output: Contribution to journalArticle

Open Access
Conjunctivitis
Atopic Dermatitis
Clinical Trials
Incidence
Placebos
2 Citations (Scopus)

Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration

Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Mar 1 2019, In : Gastroenterology. 156, 4, p. 838-842 5 p.

Research output: Contribution to journalEditorial

Gastrointestinal Diseases
Research Personnel
1 Citation (Scopus)

Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis

Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E. A. L. & Colombel, J. F., Jan 1 2019, In : Gut.

Research output: Contribution to journalArticle

Eosinophilic Esophagitis
Epidemiology
Population
Crohn Disease
Incidence
11 Citations (Scopus)

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis

HEROES Study Group, Feb 1 2019, In : Gastroenterology. 156, 3, p. 592-603.e10

Research output: Contribution to journalArticle

Eosinophilic Esophagitis
Interleukin-13
Monoclonal Antibodies
Placebos
Eosinophils
5 Citations (Scopus)

Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis

Dellon, E. S., Katzka, D. A., Collins, M. H., Gupta, S. K., Lan, L., Williams, J. & Hirano, I., Mar 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 4, p. 666-673.e8

Research output: Contribution to journalArticle

Eosinophilic Esophagitis
Budesonide
Suspensions
Safety
Placebos